ECSP22046595A - Procesos e intermediario para la preparaci?n de oxetan-2-ilmetanamina - Google Patents
Procesos e intermediario para la preparaci?n de oxetan-2-ilmetanaminaInfo
- Publication number
- ECSP22046595A ECSP22046595A ECSENADI202246595A ECDI202246595A ECSP22046595A EC SP22046595 A ECSP22046595 A EC SP22046595A EC SENADI202246595 A ECSENADI202246595 A EC SENADI202246595A EC DI202246595 A ECDI202246595 A EC DI202246595A EC SP22046595 A ECSP22046595 A EC SP22046595A
- Authority
- EC
- Ecuador
- Prior art keywords
- preparation
- ilmethanamine
- oxetan
- processes
- salt
- Prior art date
Links
- 150000001875 compounds Chemical class 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D305/00—Heterocyclic compounds containing four-membered rings having one oxygen atom as the only ring hetero atoms
- C07D305/02—Heterocyclic compounds containing four-membered rings having one oxygen atom as the only ring hetero atoms not condensed with other rings
- C07D305/04—Heterocyclic compounds containing four-membered rings having one oxygen atom as the only ring hetero atoms not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
- C07D305/06—Heterocyclic compounds containing four-membered rings having one oxygen atom as the only ring hetero atoms not condensed with other rings having no double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to the ring atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/14—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
- Y02P20/00—Technologies relating to chemical industry
- Y02P20/50—Improvements relating to the production of bulk chemicals
- Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Plural Heterocyclic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Epoxy Compounds (AREA)
- Agricultural Chemicals And Associated Chemicals (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
Abstract
Un proceso e intermediario para la preparaci?n de un compuesto de f?rmula I: o una sal del mismo.
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201962946146P | 2019-12-10 | 2019-12-10 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ECSP22046595A true ECSP22046595A (es) | 2022-07-29 |
Family
ID=74003942
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ECSENADI202246595A ECSP22046595A (es) | 2019-12-10 | 2022-06-10 | Procesos e intermediario para la preparaci?n de oxetan-2-ilmetanamina |
Country Status (28)
| Country | Link |
|---|---|
| US (1) | US12473267B2 (es) |
| EP (1) | EP4073051B1 (es) |
| JP (1) | JP7292517B2 (es) |
| KR (1) | KR102635237B1 (es) |
| CN (1) | CN114728923B (es) |
| AU (1) | AU2020401539B2 (es) |
| CL (1) | CL2022001511A1 (es) |
| CO (1) | CO2022008127A2 (es) |
| DK (1) | DK4073051T3 (es) |
| EC (1) | ECSP22046595A (es) |
| ES (1) | ES2975599T3 (es) |
| FI (1) | FI4073051T3 (es) |
| HR (1) | HRP20240343T1 (es) |
| HU (1) | HUE067201T2 (es) |
| IL (1) | IL292707B2 (es) |
| LT (1) | LT4073051T (es) |
| MA (1) | MA58104B1 (es) |
| MD (1) | MD4073051T2 (es) |
| MX (1) | MX2022006984A (es) |
| PE (1) | PE20230183A1 (es) |
| PH (1) | PH12022551403A1 (es) |
| PL (1) | PL4073051T3 (es) |
| PT (1) | PT4073051T (es) |
| RS (1) | RS65238B1 (es) |
| SI (1) | SI4073051T1 (es) |
| UA (1) | UA127884C2 (es) |
| WO (1) | WO2021118906A1 (es) |
| ZA (1) | ZA202205170B (es) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP4073051B1 (en) | 2019-12-10 | 2024-02-07 | Eli Lilly and Company | Process and intermediate for the preparation of oxetan-2-ylmethanamine |
| CN116217522B (zh) * | 2023-02-22 | 2025-06-24 | 广东莱佛士制药技术有限公司 | Glp-1受体激动剂关键中间体的手性纯化方法 |
| WO2026132278A2 (en) * | 2024-12-20 | 2026-06-25 | F. Hoffmann-La Roche Ag | Process for the preparation of oxetane derivatives |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7208140B2 (en) * | 2003-02-19 | 2007-04-24 | Schering Aktiengesellschaft | Trimeric macrocyclic substituted benzene derivatives |
| MD4557C1 (ro) * | 2011-05-06 | 2018-10-31 | Egis Gyogysszegyar Nyilvanosan Mukodo Reszvenytarsasag | Procedeu de obţinere a rivaroxabanului şi un compus intermediar utilizat în acest procedeu |
| US9376409B2 (en) * | 2012-05-09 | 2016-06-28 | Boehringer Ingelheim International Gmbh | Methods for making oxetan-3-ylmethanamines |
| WO2018109607A1 (en) * | 2016-12-16 | 2018-06-21 | Pfizer Inc. | Glp-1 receptor agonists and uses thereof |
| CA3045644C (en) | 2018-06-13 | 2024-01-16 | Pfizer Inc. | Glp-1 receptor agonists and uses thereof |
| FI3806855T3 (fi) | 2018-06-15 | 2023-05-04 | Pfizer | Glp-1 -reseptorin agonisteja ja niiden käyttöjä |
| CN109265389B (zh) * | 2018-08-31 | 2020-08-18 | 南京富润凯德生物医药有限公司 | 2-(氨基甲基)-1-氧杂-7-氮杂螺[3.5]壬烷衍生物、中间体及其制备方法 |
| EP4073051B1 (en) | 2019-12-10 | 2024-02-07 | Eli Lilly and Company | Process and intermediate for the preparation of oxetan-2-ylmethanamine |
-
2020
- 2020-12-07 EP EP20829133.6A patent/EP4073051B1/en active Active
- 2020-12-07 UA UAA202201389A patent/UA127884C2/uk unknown
- 2020-12-07 FI FIEP20829133.6T patent/FI4073051T3/fi active
- 2020-12-07 MX MX2022006984A patent/MX2022006984A/es unknown
- 2020-12-07 AU AU2020401539A patent/AU2020401539B2/en active Active
- 2020-12-07 LT LTEPPCT/US2020/063546T patent/LT4073051T/lt unknown
- 2020-12-07 PE PE2022001046A patent/PE20230183A1/es unknown
- 2020-12-07 US US17/779,447 patent/US12473267B2/en active Active
- 2020-12-07 WO PCT/US2020/063546 patent/WO2021118906A1/en not_active Ceased
- 2020-12-07 HU HUE20829133A patent/HUE067201T2/hu unknown
- 2020-12-07 JP JP2022534655A patent/JP7292517B2/ja active Active
- 2020-12-07 KR KR1020227018626A patent/KR102635237B1/ko active Active
- 2020-12-07 MD MDE20221148T patent/MD4073051T2/ro unknown
- 2020-12-07 HR HRP20240343TT patent/HRP20240343T1/hr unknown
- 2020-12-07 SI SI202030381T patent/SI4073051T1/sl unknown
- 2020-12-07 CN CN202080082957.9A patent/CN114728923B/zh active Active
- 2020-12-07 MA MA58104A patent/MA58104B1/fr unknown
- 2020-12-07 RS RS20240243A patent/RS65238B1/sr unknown
- 2020-12-07 PT PT208291336T patent/PT4073051T/pt unknown
- 2020-12-07 DK DK20829133.6T patent/DK4073051T3/da active
- 2020-12-07 IL IL292707A patent/IL292707B2/en unknown
- 2020-12-07 ES ES20829133T patent/ES2975599T3/es active Active
- 2020-12-07 PL PL20829133.6T patent/PL4073051T3/pl unknown
- 2020-12-07 PH PH1/2022/551403A patent/PH12022551403A1/en unknown
-
2022
- 2022-05-10 ZA ZA2022/05170A patent/ZA202205170B/en unknown
- 2022-06-08 CL CL2022001511A patent/CL2022001511A1/es unknown
- 2022-06-08 CO CONC2022/0008127A patent/CO2022008127A2/es unknown
- 2022-06-10 EC ECSENADI202246595A patent/ECSP22046595A/es unknown
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CO2020014586A2 (es) | Compuestos | |
| CO2022002637A2 (es) | Proceso de fabricación de moduladores de cftr | |
| CO2020000527A2 (es) | Compuestos y composiciones para tratar afecciones asociadas con la actividad nlrp | |
| CR20220251A (es) | Nuevos derivados de metilquinazolinona | |
| AR111304A1 (es) | Métodos para sintetizar un inhibidor de mcl-1 | |
| EA201791420A1 (ru) | Соединения триазолопиримидина и их применения | |
| MX380394B (es) | Compuesto novedoso de bifenilo o una sal del mismo. | |
| ECSP17054980A (es) | Inhibidores selectivos de bace1 | |
| CL2022001511A1 (es) | Procesos e intermediario para la preparación de oxetan-2-ilmetanamina | |
| CO2020012574A2 (es) | Método para la preparación de una 1,2,4-triazolona 2,4,5-trisustituida | |
| CL2019000857A1 (es) | Compuestos heterocíclicos y su uso para prevenir o tratar las infecciones bacterianas. | |
| CO2018007008A2 (es) | "procesos mejorados para la preparación de osimertinib (azd9291) o una sal del mismo y "azd9291 anilina" o una sal del mismo" | |
| CO2019008110A2 (es) | Activador de nrf2 | |
| MX2024008671A (es) | Metodos de tratamiento de infecciones micobacterianas usando compuestos de tetraciclina. | |
| MX2022005522A (es) | Formas de sal de un receptor de componente c5a de complemento. | |
| MX2025003091A (es) | Metodo para producir derivado de heterociclideno acetamida | |
| DOP2019000021A (es) | Derivado de triazolopirazinona útil como un inhibidor de pde1 humana | |
| EA201990238A1 (ru) | ФОСФОРСОДЕРЖАЩИЕ ПРОЛЕКАРСТВА СТИМУЛЯТОРОВ sGC | |
| CL2017001276A1 (es) | Derivados de benzotiazol antibacterianos | |
| MX2022000651A (es) | Proceso mejorado para preparar ozanimod. | |
| UA127754U (uk) | Поліетергуанідингідрохлорид як бактерицидна речовина | |
| AR113783A1 (es) | Compuestos moduladores de cftr, métodos para preparar formas cristalinas, y composiciones farmacéuticas | |
| AR115865A2 (es) | Compuestos terapéuticos | |
| AR114477A1 (es) | Método para la preparación de una 1,2,4-triazolona 2,4,5-trisustituida | |
| UA127755U (uk) | Поліетергуанідингідрохлорид як бактерицидна речовина |